Jim Van Meerten is an advisor to Marketocracy Capital Management and writes on financial subjects here and on Barchart Portfolio Blogs. He earned a BS in Accounting and Business Administration from Berry College; a Juris Doctorate from the Woodrow Wilson School of Law; and attended... More
- My company:
- Marketocracy Capital Management
- My blog:
- Barchart Portfolio Blogs
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
-
Instablogged Stocks
Stocks that instabloggers have most recently written about -
Latest Instablog Posts
- 1 3 Dreamy Small Cap Stocks
- 2 Gunson Resources Receives Notice Of Withdraw...
- 3 Vascepa, Broadens Cardiovascular Therapy, It...
- 4 Dell: Battle Royale For Control Offers Surpr...
- 5 Optionity Daily Report 05/23/2013
-
Top Instablogs
See all Top Instablogs »










Gilead Sciences - GILD - Barchart Chart Of The Day 0 comments
Barchart.coms Chart of the Day - Gilead Sciences (GILD)
Barchart Research Team - BC - Thu Aug 02, 6:00PM CDT
Related Stocks
GILD - Gilead Sciences
The "Chart of the Day" is Gilead Sciences (GILD), which showed up on Thursday's Barchart "All-Time High" list. Gilead gapped higher on Thursday, posted an all-time high of $58.84 and closed up +6.82%. TrendSpotter has been long Gilead since June 27 at $51.25. Gilead surged Thursday after rival drugmaker Bristol-Myers suspended a study of one of its hepatitis C drug candidates after at least one patient suffered heart failure. Bristol-Myers has been in a race with Gilead to develop the next generation of hepatitis C treatments, according to Bernstein analyst Dr. Tim Anderson. Gilead bought hepatitis C drug developer Pharmasset in January for $11.1 billion. The deal gave it several experimental hepatitis treatments, including one labeled GS-7977 that many analysts see as promising. Credit Suisse analyst Catherine Arnold said that because Gilead's GS-7977 isn't associated with major safety issues, investors will view the company's hepatitis C program more positively. Gilead Sciences with a market cap of $41.1 billion, is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer.
(click to enlarge)
How we found the Chart of the Day:
We found the "Chart of the Day" by scanning the Barchart "All Time High" list. In order to get to that list, we first clicked on the Stocks menu item on the Barchart home page, then on the "All Time Highs" menu item on the left menu bar. We then sorted the list by percentage gainers by clicking on the "Percent" column title. A stock that has posted a new All-Time high is typically showing strong upside momentum.
The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart links for further information:
Quotes and Charts
Quote
Detailed Quote
Chart
Technical Analysis
Technicals Summary
Trader's Cheat Sheet™
Barchart Opinions
Barchart Opinion
Barchart Snapshot
Trading Strategies
Company Info
Company Profile
Key Statistics
Ratios
Income Statement-Quarterly
Income Statement-Annual
Balance Sheet-Current
Balance Sheet-Annual
Chart of the Day Archive
View Past Chart of the Day Reports
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Share this Instablog
Latest Followers
StockTalks
-
$WCN - 96% Barchart technical buy signals - 8 new highs and up 12.95% in the last month - Relative Strength Index 73.90%
about 4 hours ago
-
$BBG - 96% Barchart technical buy signals - 9 new highs and up 20.96% in the last month - Relative Strength Index 65.22%
about 4 hours ago
-
$BYI - 96% Barchart technical buy signals - 4 new highs and up 13.85% in the last month - Relative Strength Index 69.26%
about 4 hours ago
More »Latest Comments
Most Commented
Posts by Themes